0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka

NCT03303794 PHASE3 TERMINATED Results posted

Total knee and hip replacements are some of the most common orthopedic procedures that require aggressive postoperative pain management. This management helps us to improve clinical outcomes such as participation in early physical therapy, hospital discharge, and patient satisfaction. Based on the recent anatomical evidence and the investigator's knowledge of the complexity of the knee joint innervation the investigator proposes a new regional anesthesia technique that provides a complete sensory blockade and better analgesia while preserving the quadriceps strength and avoiding the potential for foot drop caused by inadvertent blockade of the common peroneal nerve.

Details

Lead sponsor	Montefiore Medical Center
Phase	PHASE3
Status	TERMINATED
Enrolment	25
Start date	Wed Oct 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Anesthesia

Interventions

• Exparel
• 0.25% bupivacaine

Countries

United States